Ascendis Pharma A/SASNDNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$43.62M
↑ 118% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-245.84M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $43.62M | +114.2% |
| 2024 | $-307.62M | +34.5% |
| 2023 | $-469.80M | +7.9% |
| 2022 | $-510.19M | -15.5% |
| 2021 | $-441.88M | -50.8% |
| 2020 | $-293.10M | -61.8% |
| 2019 | $-181.09M | -28.0% |
| 2018 | $-141.45M | -47.3% |
| 2017 | $-96.04M | -57.8% |
| 2016 | $-60.85M | - |